Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes—Practice resource of the National Society of Genetic Counselors-Reference-Cited by-同舟云学术

Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes—Practice resource of the National Society of Genetic Counselors

Published:2021-01-07 Issue:2 Volume:30 Page:342-360
ISSN:1059-7700
Container-title:Journal of Genetic Counseling
language:en
Short-container-title:Jrnl of Gene Coun

Author:

Berliner Janice L.¹,Cummings Shelly A.²,Boldt Burnett Brittany³,Ricker Charité N.⁴

Affiliation:

1. Genetic Counseling Department Bay Path University East Longmeadow MA USA

2. Myriad Genetics, Inc Salt Lake City UT USA

3. Sharp HealthCare San Diego CA USA

4. Keck School of Medicine University of Southern California Los Angeles CA USA

Publisher

Wiley

Subject

Genetics(clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgc4.1374

Reference158 articles.

1. Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population‐based biobank;Abul‐Husn N. S.;Genome Medicine,2019

2. updated recommendations regarding analysis and reporting of secondary findings in clinical genome‐scale sequencing;ACMG policy statement;Genetics in Medicine,2015

3. ACMG Policy Statement of the Social Ethical and Legal Issues Committee. (1999). Retrived fromhttps://www.acmg.net/PDFLibrary/Duty‐to‐Recontact.pdf

4. Hereditary breast and ovarian cancer syndrome;ACOG Committee on Practice Bulletins;Gynecologic Oncology,2009

5. Diagnostic Accuracy of the Gail Model in the Black Women?s Health Study

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Queering genomics: How cisnormativity undermines genomic science;Human Genetics and Genomics Advances;2024-07

2. Development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in Japanese patients with breast cancer based on Japanese Organization of Hereditary Breast and Ovarian Cancer registry data;2024-06-11

3. Hereditary Cancer Syndrome Carriers: Feeling Left in the Corner;Seminars in Oncology Nursing;2024-06

4. Personalised Medicine and Molecular Docking: Tailoring Drug Discovery for Individual Patients;Unravelling Molecular Docking - From Theory to Practice [Working Title];2024-04-29

5. Genetic counselors' and community clinicians' implementation and perceived barriers to informed consent during pre‐test counseling for hereditary cancer risk;Journal of Genetic Counseling;2024-03-13